Workflow
研究和试验发展
icon
Search documents
海尔取得空调系统用传输管组件专利
Sou Hu Cai Jing· 2025-12-30 10:22
Group 1 - The State Intellectual Property Office of China has granted a patent titled "Transmission Pipe Component for Air Conditioning Systems and Air Conditioning Systems" to multiple subsidiaries of Haier, with the announcement number CN119687538B and application date of September 2023 [1] - Qingdao Haier Smart Building Technology Co., Ltd. was established in 2003, has a registered capital of 100 million RMB, and has participated in 1,031 bidding projects with 436 patents [1] - Qingdao Haier Air Conditioning Electronics Co., Ltd. was founded in 1999, has a registered capital of approximately 967.09 million RMB, and has participated in 4,706 bidding projects with 5,000 patents [1][2] Group 2 - Qingdao Haier Air Conditioner Co., Ltd. was established in 1996, has a registered capital of approximately 936.38 million RMB, and has participated in 4,866 bidding projects with 5,000 patents [2] - Qingdao Haier Intelligent Technology Research and Development Co., Ltd. was founded in 2014, has a registered capital of 13 million RMB, and has participated in 7 bidding projects with 5,000 patents [2] - Haier Smart Home Co., Ltd. was established in 1994, has a registered capital of approximately 943.81 million RMB, and has participated in 1,887 bidding projects with 5,000 patents [2]
深圳市光因科技有限公司获“A+轮”融资,金额亿级人民币
Sou Hu Cai Jing· 2025-12-30 03:15
通过天眼查大数据分析,深圳市光因科技有限公司共对外投资了5家企业,知识产权方面有商标信息42 条,专利信息20条,此外企业还拥有行政许可16个。 天眼查信息显示,深圳市光因科技有限公司的股东为:温言杰、深圳市和木相处新技术有限公司、深圳 市老温新技术合伙企业(有限合伙)、徐州高鑫梅岭顺势创业投资合伙企业(有限合伙)、深圳市光玲 科技合伙企业(有限合伙)。 来源:市场资讯 12月28日,天眼查融资历程显示,深圳市光因科技有限公司近日获得"A+轮"融资,涉及融资金额亿级 人民币,投资机构为啟赋资本,神骐资本。 资料显示,深圳市光因科技有限公司法定代表人为温言杰,成立于2022年,位于深圳市,是一家以从事 研究和试验发展为主的企业。企业注册资本591.665193万人民币,并已于2025年完成了A+轮,交易金 额亿级人民币。 ...
海南恒上贸易有限公司成立,注册资本1000万人民币
Sou Hu Cai Jing· 2025-12-30 02:16
Group 1 - The establishment of Hainan Hengshang Trading Co., Ltd. has been registered with a legal representative named Wang Yu and a registered capital of 10 million RMB [1] - Hainan Hengshang Investment Co., Ltd. holds 100% ownership of Hainan Hengshang Trading Co., Ltd. [1] - The business scope includes internet sales (excluding goods requiring permits), trade brokerage, domestic trade agency, software development, information technology consulting, engineering and technical research and development, medical research and development, industrial design services, professional design services, socio-economic consulting, environmental consulting, advertising design and agency, business agency services, ticketing agency services, and personal business services [1] Group 2 - The company is classified under the national standard industry of scientific research and technical service industry, specifically in engineering and technical research and development [1] - The registered address of the company is located at 257 Yuedong Street, Tianya District, Sanya City, Hainan Province [1] - The company is categorized as a limited liability company with natural person investment or control, and its business term is set until December 29, 2025, with no fixed duration [1]
成都普巴智能科技有限公司获“天使轮”融资,金额数千万人民币
Sou Hu Cai Jing· 2025-12-30 01:40
来源:市场资讯 12月29日,天眼查融资历程显示,成都普巴智能科技有限公司近日获得"天使轮"融资,涉及融资金额数 千万人民币,投资机构为成都高投集团,力鼎资本。 资料显示,成都普巴智能科技有限公司法定代表人为秦辉,成立于2024年,位于成都市,是一家以从事 研究和试验发展为主的企业。企业注册资本1000万人民币,并已于2025年完成了天使轮,交易金额数千 万人民币。 通过天眼查大数据分析,成都普巴智能科技有限公司共对外投资了1家企业,专利信息5条,此外企业还 拥有行政许可2个。 天眼查信息显示,成都普巴智能科技有限公司的股东为:上海普巴协同管理咨询合伙企业(有限合 伙)、上海伍友管理咨询合伙企业(有限合伙)、成都中科微信息技术研究院有限公司。 ...
成都星卫讯科技有限公司获“A+轮”融资,金额超亿人民币
Sou Hu Cai Jing· 2025-12-30 01:40
通过天眼查大数据分析,成都星卫讯科技有限公司共对外投资了3家企业,知识产权方面有商标信息4 条,专利信息11条,此外企业还拥有行政许可2个。 天眼查信息显示,成都星卫讯科技有限公司的股东为:万明刚、成都星卫讯企业管理合伙企业(有限合 伙)、成都卫信汇诚企业管理咨询中心(有限合伙)、苏州博娜企业管理合伙企业(有限合伙)、成都 博源新程创业投资合伙企业(有限合伙)。 来源:市场资讯 12月29日,天眼查融资历程显示,成都星卫讯科技有限公司近日获得"A+轮"融资,涉及融资金额超亿 人民币,投资机构为元禾原点,博源资本,融玺创投,成都高投集团,新尚投资。 资料显示,成都星卫讯科技有限公司法定代表人为万明刚,成立于2021年,位于成都市,是一家以从事 研究和试验发展为主的企业。企业注册资本1221.383万人民币,并已于2025年完成了A+轮,交易金额 超亿人民币。 ...
厦门宝仁控股有限公司成立,注册资本5000万人民币
Sou Hu Cai Jing· 2025-12-29 16:52
经营范围含以自有资金从事投资活动;技术服务、技术开发、技术咨询、技术交流、技术转让、技术推 广;第一类医疗器械销售;第二类医疗器械销售;医学研究和试验发展;自然科学研究和试验发展;技 术进出口;货物进出口;技术推广服务;企业管理;企业管理咨询;自有资金投资的资产管理服务;融 资咨询服务。(除依法须经批准的项目外,凭营业执照依法自主开展经营活动)许可项目:第三类医疗 器械经营。(依法须经批准的项目,经相关部门批准后方可开展经营活动,具体经营项目以相关部门批 准文件或许可证件为准)。 企业名称厦门宝仁控股有限公司法定代表人张国锋注册资本5000万人民币国标行业科学研究和技术服务 业>研究和试验发展>工程和技术研究和试验发展地址企业类型有限责任公司(自然人投资或控股的法 人独资)营业期限2025-12-29至无固定期限 天眼查显示,近日,厦门宝仁控股有限公司成立,法定代表人为张国锋,注册资本5000万人民币,由厦 门宝太控股集团有限公司全资持股。 序号股东名称持股比例1厦门宝太控股集团有限公司100% 来源:市场资讯 ...
毕得医药:多名股东拟合计减持不超过0.95%公司股份
Mei Ri Jing Ji Xin Wen· 2025-12-29 11:48
截至发稿,毕得医药市值为59亿元。 每经头条(nbdtoutiao)——绕开光刻机"卡脖子",中国新型芯片问世!专访北大孙仲:支撑AI训练和 具身智能,可在28纳米及以上成熟工艺量产 每经AI快讯,毕得医药(SH 688073,收盘价:64.44元)12月29日晚间发布公告称,截至本公告披露 日,上海毕得医药科技股份有限公司股东李怡静持有公司无限售条件流通股约28万股,占公司股份总数 的0.31%。股东陈俊持有公司无限售条件流通股约8.81万股,占公司股份总数的0.1%。股东李黎持有公 司无限售条件流通股约21.45万股,占公司股份总数的0.24%。股东杜鹃持有公司无限售条件流通股约 16.8万股,占公司股份总数的0.18%。股东耿勇持有公司无限售条件流通股约12.3万股,占公司股份总 数的0.14%。股东蒋亚妹持有公司无限售条件流通股约2.69万股,占公司股份总数的0.03%。李怡静、陈 俊、李黎、杜鹃、耿勇、蒋亚妹,合计持有毕得医药0.99%的股份。 因股东自身流动性需求,股东李怡静、陈俊、李黎、杜鹃、耿勇、蒋亚妹计划根据市场情况拟于本减持 计划披露之日起3个交易日后的3个月内通过集中竞价方式减持其所持有 ...
【新华网】我国交付国际热核聚变实验堆ITER校正场线圈采购包任务
Xin Hua Wang· 2025-12-29 03:02
Group 1 - The core viewpoint of the article highlights the successful completion of the procurement package for the ITER correction field coils, marking a significant achievement in China's superconducting magnet engineering field [1] - The ITER correction field coils consist of three groups of 18 coils, which are crucial components of the main magnetic system of the ITER device, affecting plasma operation parameters directly [1] - The manufacturing of the correction field coils was entirely independently developed and produced by China, with a research and certification phase starting in 2010 and mass production beginning in 2016, culminating in a 15-year completion timeline [1] Group 2 - The research team emphasized the high welding requirements and strict dimensional control needed for the large-sized correction field coils, along with the challenging testing environment and acceptance criteria [1] - The Institute of Plasma Physics at the Hefei Institutes of Physical Science, Chinese Academy of Sciences, plays a significant role in the ITER project, handling numerous procurement packages and contracts, which constitute a large portion of China's responsibilities in the ITER procurement tasks [1]
国产自研拉曼光谱仪揭三星堆象牙之谜
仪器信息网· 2025-12-27 09:01
特别提示 微信机制调整,点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标,否则很可能无法看到我们的推送。 近日,中国科学院空天信息创新研究院(空天院)广州园区研究员王振友研究团队研制的显微时间门控拉曼光谱仪,在三星 堆象牙考古研究方面取得进展。相关成果在国际学术期刊《美国化学会-应用材料与界面》发表。 三星堆出土象牙历经三千余年,是研究古蜀文明的重要载体。由于长期埋藏于地下,这些象牙持续受到地下水、可溶盐及微 生物等因素侵蚀,外观虽大体完整,内部结构却已十分脆弱。对其进行科学保护与修复,需在无损条件下获取其成分与微结 构信息,并具备微米级分辨率,以应对锈蚀和腐蚀分布不均的难题。研究团队通过关键技术与核心部件创新,研制的这一显 微时间门控拉曼光谱仪,显著提升了拉曼光谱在强荧光条件下的抗干扰能力,最终利用该仪器对三星堆出土的四块象牙碎片 进行无损检测,成功揭示了象牙在长期地质作用下的老化过程。 研究显示,四块象牙碎片的荧光强度差异显著,其中两块在传统连续光拉曼条件下几乎无法得到有效信号。而在时间门控拉 曼检测中,荧光干扰被有效抑制,强荧光样品的拉曼信噪比提升超过20倍,象牙内部成分差异清晰显现。分析表 ...
“航天小鼠”和地面小鼠行为有啥差异?总台记者现场探访
Yang Shi Xin Wen· 2025-12-27 05:31
Core Viewpoint - The experiment involving small mammals in China's space station marks a significant step in understanding the effects of space environments on mammalian reproduction and behavior, providing a foundation for future human space exploration [18][19]. Group 1: Experiment Overview - Four small mice were sent to the Chinese space station aboard the Shenzhou 21 mission, marking the first small mammal scientific experiment in the space station [1]. - After approximately two weeks in space, the mice returned to Earth, with two of them successfully giving birth to a litter of nine pups [3][5]. Group 2: Behavioral Observations - Initial observations indicate that the behavior of the space-returned mice differs from that of ground-based mice, particularly in nurturing their offspring [8]. - The space group mice showed a greater reliance on their nesting environment compared to the ground control group, with notable differences in parental behaviors [11][13]. Group 3: Scientific Implications - The experiment aims to explore physiological changes in mammals due to space conditions and their ability to reproduce in such environments, which is crucial for long-term human space missions [21][22]. - The findings from this experiment could lead to the development of targeted treatments or medications to address the physiological impacts of space travel on humans [22][23].